Colorectal cancer trials in China

In China 613 Also abroad 1929

613 trials · From ClinicalTrials.gov, checked 10 Nov 2026. Ask the study team whether a trial fits you.

Phase 2/3Enrolling by invitationTrial-stage medicine
Evaluating the Efficacy of Chidamide in the Treatment of Initial Unresectable Metastatic Colorectal Cancer With High Expression of SULF1
Where
Hangzhou
Age
18 years and over
People
126
Run by
Sir Run Run Shaw Hospital
See details and how to joinNCT07927049Registry updated 2026-11-09
Phase 2/3Enrolling by invitationTrial-stage medicine
Evaluating the Efficacy of Chidamide in Advanced Refractory Colorectal Cancer With High SULF1 Expression
Where
Hangzhou
Age
18 years and over
People
17
Run by
Sir Run Run Shaw Hospital
See details and how to joinNCT07927075Registry updated 2026-11-09
No phaseRecruitingResearch participation
Pre- and On-treatment Multi-omics Profiling of Locally Advanced Rectal Cancer
Where
Fuzhou
People
100
Run by
Fujian Medical University Union Hospital
See details and how to joinNCT07920770Registry updated 2026-11-06
Phase 1/2RecruitingTrial-stage medicine
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Where
Changchun, Hangzhou, Harbin, Nanjing, Shanghai, Tianjin, Zhengzhou
Age
18 years and over
People
910 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT06324357Registry updated 2026-11-05
Phase 3RecruitingTrial-stage medicine
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Where
Beijing, Ch’ang-ch’un, Changsha, Chengdu, Chifeng, Foshan, Fuzhou, Guangzhou, Haikou, Hangzhou, Harbin, Jinan, Kunming, Luzhou, Nanchang, Nanjing, Ningbo, Shanghai, Shenyang, Shenzhen, Shijiazhuang, Tianjin, Wenzhou, Wuhan, Yueyang, Zhengzhou, Zhuhai
Age
18 years and over
People
900 worldwide
Run by
Summit Therapeutics
See details and how to joinNCT07228832Registry updated 2026-11-05
Phase 3RecruitingTrial-stage medicine
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
Where
Beijing, Chengdu, Guangzhou, Hangzhou, Hong Kong, Meizhou, Nanchang, Nanjing, Nanning, Shanghai, Wuhan
Age
18 years and over
People
1,020 worldwide
Run by
EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT07549412EU 2025-524648-37-00Registry updated 2026-11-05
No phaseRecruitingResearch participation
A Patient-Derived 3D Bioprinted Colorectal Cancer-Stroma-Immune Triad Model Uncovers Microenvironmental Mechanisms of Chemoresistance and Immune Evasion
Where
Ningbo
Age
18 years and over
People
60
Run by
Peking Union Medical College Hospital
See details and how to joinNCT07919418Registry updated 2026-11-05
No phaseNot yet recruitingResearch participation
RAPID for Unresectable Colorectal Liver Metastases
Where
Guangzhou
Age
18 years to 70 years
People
10
Run by
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT07919951Registry updated 2026-11-05
Phase 2RecruitingTrial-stage medicine
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Where
Beijing, Changsha, Hangzhou, Shanghai
Age
18 years and over
People
111 worldwide
Run by
Bayer
See details and how to joinNCT06760819EU 2024-517419-62-00Registry updated 2026-11-04
Phase 3RecruitingTrial-stage medicine
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Where
Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Kunming, Nanchang, Nanjing, Nanning, Shanghai, Shenzhen, Taiyuan, Wanzhou, Wenzhou, Wuhan, Xiamen, Xi'an, Zhengzhou
Age
18 years and over
People
477 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06997497EU 2024-517232-22-00Registry updated 2026-11-04
Phase 1RecruitingTrial-stage medicine
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Where
Beijing, Tianjin
Age
18 years and over
People
421 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07114601EU 2025-522367-15-00Registry updated 2026-11-04
Phase 1RecruitingTrial-stage medicine
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Where
Shanghai
Age
18 years and over
People
340 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07213791EU 2025-521887-37-00Registry updated 2026-11-04
Phase 1Not yet recruitingTrial-stage medicine
SND002 Cell Injection in Participants With Advanced Malignant Solid Tumors
Where
Guiyang, Hangzhou
Age
18 years to 80 years
People
78
Run by
Guizhou Sinorda Pharmaceutical Co., Ltd.
See details and how to joinNCT07903857Registry updated 2026-11-04
Phase 2RecruitingTrial-stage medicine
Circulating Tumor DNA Methylation-Guided Adjuvant Therapy Decision-Making in Patients With Resectable Colorectal Cancer Liver Metastases After Resection
Where
Shanghai
Age
18 years to 75 years
People
220
Run by
Fudan University
See details and how to joinNCT07917104Registry updated 2026-11-04
No phaseNot yet recruitingResearch participation
Real-World Study: Panitumumab N01 vs Cetuximab Plus FOLFOX in First-Line RAS Wild-Type mCRC
Where
Fuzhou
Age
18 years and over
People
610
Run by
Fujian Medical University Union Hospital
See details and how to joinNCT07917429Registry updated 2026-11-04
Phase 1/2RecruitingTrial-stage medicine
A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
Where
Dalian, Guangzhou, Hangzhou, Wuhan
Age
18 years and over
People
225 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT05379595EU 2023-506517-22-00Registry updated 2026-11-03
Phase 3RecruitingTrial-stage medicine
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Where
Beijing, Changchun, Changsha, Guangzhou, Hangzhou, Harbin, Huizhou, Nanchang, Shanghai, Shenyang, Shenzhen, Sichuan, Taiyuan, Tianjin, Wuhan
Age
18 years and over
People
1,000 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06662786EU 2024-513852-13-00Registry updated 2026-11-03
Phase 3RecruitingTrial-stage medicine
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Where
Beijing, Changchun, Changsha, Chengdu, Ganzhou, Guangzhou, Hangzhou, Harbin, Huizhou, Lanzhou, Nanchang, Shanghai, Shenyang, Tianjin, Wuhan
Age
18 years and over
People
700 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06750094EU 2024-513853-66-00Registry updated 2026-11-03
No phaseNot yet recruitingTrial-stage medicine
Feasibility Study of Huangqi Yangyuan Formula for Capecitabine-Induced Adverse Reactions in Advanced Colorectal Cancer
Where
Shijiazhuang
Age
18 years to 80 years
People
35
Run by
Huanfang Fan
See details and how to joinNCT07913516Registry updated 2026-11-03
No phaseRecruitingResearch participation
Pre-emptive Endoscopic Vacuum Therapy Reduces the Incidence of Anastomotic Leakage After Colorectal Cancer Surgery
Where
Nanchong
Age
18 years to 85 years
People
110
Run by
Nanchong Central Hospital
See details and how to joinNCT07208786Registry updated 2026-11-02
Phase 3RecruitingTrial-stage medicine
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Where
Beijing, Changsha, Chengdu, Chongqing, Foshan, Fuzhou, Guangzhou, Hangzhou, Hefei, Hohhot, Jinan, Jining, Jinzhou, Lanzhou, Meizhou, Nanchang, Nanning, Shanghai, Shijiazhuang, Tianjin, Wenzhou, Wuhan, Xi'an
Age
18 years and over
People
700 worldwide
Run by
Incyte Corporation
See details and how to joinNCT07284849EU 2025-523735-19-00Registry updated 2026-10-30
Phase 1/2RecruitingTrial-stage medicine
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
Where
Beijing, Changsha, Chengdu, Fuzhou, Shanghai, Wuhan
Age
18 years and over
People
220 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06428409EU 2023-508703-21-00Registry updated 2026-10-29
Phase 1/2RecruitingTrial-stage medicine
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
Where
Beijing, Hangzhou, Wuhan, Xi’an, Zhengzhou
Age
18 years and over
People
430 worldwide
Run by
Pfizer
See details and how to joinNCT04557449EU 2024-512120-11-00Registry updated 2026-10-28
Phase 2RecruitingTrial-stage medicine
Ivarmacitinib Combined With Camrelizumab and Fruquintinib for Patients With Metastatic Colorectal Cancer After Failure of Second-line or Later Treatment
Where
Wuhan
Age
18 years to 75 years
People
33
Run by
Renmin Hospital of Wuhan University
See details and how to joinNCT07896096Registry updated 2026-10-28
Phase 2RecruitingTrial-stage medicine
Toripalimab Plus Cetuximab and Irinotecan for Second-Line Right-Sided RAS/BRAF Wild-Type Advanced Colon Cancer Phase II Study
Where
Beijing
Age
18 years and over
People
46
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07896681Registry updated 2026-10-27

All Colorectal cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error